How much funding has Prolifagen raised?

Prolifagen has disclosed $3M raised across 1 round.

Where is Prolifagen headquartered?

Prolifagen is headquartered in Doylestown, US.

Prolifagen

Doylestown, US · Founded 2025 · Delaware corporation

Prolifagen is developing PRO302, a therapy designed to induce cardiomyocyte proliferation to regenerate damaged heart muscle tissue and restore cardiac function. The company focuses on treatments for heart disease and heart attack recovery.

Biotech Longevity Medical Devices

Founders & leadership

Andreas BaderExecutive

William HoustonExecutive

Michael BehrExecutive

Claudine BruckNamed on SEC filing

Board

M. Alexander ShawBoard director

Reported raises · per SEC filings

Form D private placements

$3M disclosed across 1 round · 2025

▶$3MraisedSep 2025 · 6 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

M. Alexander ShawDirector
Andreas BaderExecutive Officer
William HoustonExecutive Officer
Michael BehrExecutive Officer, Director
Claudine BruckExecutive Officer, Director

Amount sold: $3M
First sale: Sep 2025
Incorporated: Corporation, Delaware, 2025
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Exagen11 shared keywordsExagen develops diagnostic and monitoring tests for autoimmune diseases, including tools to distinguish connective tissue disease and assess lupus prognosis and progression. The company serves healthcare professionals and patients with chronic autoimmune conditions.

Nivagen6 shared keywordsNivagen is a specialty pharmaceutical company that develops, manufactures, and markets generic and specialty drugs including sterile injectables and 505(b)(2) products, operating manufacturing facilities in California, Europe, and Japan. The company provides contract development and manufacturing (CDMO) services including custom drug product development, out-licensing, and 503B compounding services for institutional channels.

Biogen Idec6 shared keywordsBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.

Companies competing with Prolifagen for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Prolifagen do?: Prolifagen is developing PRO302, a therapy designed to induce cardiomyocyte proliferation to regenerate damaged heart muscle tissue and restore cardiac function. The company focuses on treatments for heart disease and heart attack recovery.
How much funding has Prolifagen raised?: Prolifagen has disclosed $3M raised across 1 round.
Where is Prolifagen headquartered?: Prolifagen is headquartered in Doylestown, US.